Roche Closes $2 Billion Deal With Flatiron Health
Roche has revealed that it’s closed it’s $1.9 billion acquisition of digital healthcare technology company Flatiron Health.
The New York city-based firm designs and develops oncology-specific electronic health record software, and supports in curating and developing real-world evidence for cancer research, writes Mass Device.
Under the acquisition deal, Flatiron will continue to operate as a separate legal entity and maintain its independence, as well as its business model, partnerships, and existing objectives.
Roche believes that the acquisition will allow both companies to accelerate their development of data-driven personalised healthcare products in the oncology field.